Skip to content

Insider · CIK 0001831215

Kinney Horn

officer

Files at IMNM (Immunome Inc.). First filing Jul 9, 2026, latest Aug 6, 2026.

In brief

Kinney Horn files SEC Form 4 as officer at IMNM (Immunome Inc.). Since Jul 9, 2026, Kinney Horn has reported 0 open-market buys worth $0 and 2 open-market sells worth $2.3M, the latest filed on Aug 6, 2026.

A track record needs three past buys with six months of prices behind them; Kinney Horn has 0, so none is measured yet.

The newest scored trade: sold $2.3M of IMNM on Aug 4, 2026, filed Aug 6, 2026, scored 33 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $2.3M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $2.3M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

IMNM: Immunome Inc.

IMNMOct 12, 2026 · close 19.15

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
IMNMsell 210b5-1
Immunome Inc.
$2.3M
90,616 shares
-100%+179% from low-7% from high
20Weak
IMNMsell 310b5-1
Immunome Inc.
$27k
1,092 shares
-100%+190% from low-10% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Aug 4, 2026 IMNM
Immunome Inc.
90,616
0.08% of outstanding
$2.3MAug 4, 2026$27k
Jul 7, 2026 IMNM
Immunome Inc.
1,092
0.00% of outstanding
$27kJul 7, 2026none

Transactions

Every row this insider has filed, 13 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 4, 2026IMNM
Immunome Inc.
MOption exercise
Common Stock10b5-1
+50,366$12.92$651k50,366Aug 6, 2026
Aug 4, 2026IMNM
Immunome Inc.
MOption exercise
Common Stock10b5-1
+40,250$10.60$427k90,616Aug 6, 2026
Aug 4, 2026IMNM
Immunome Inc.
SOpen-market sale
Common Stock10b5-1
-90,616$25.09$2.3M0Aug 6, 2026
Aug 4, 2026IMNM
Immunome Inc.
MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
-50,366$0.00$078,542Aug 6, 2026
Aug 4, 2026IMNM
Immunome Inc.
MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
-40,250$0.00$0120,750Aug 6, 2026
Jul 23, 2026IMNM
Immunome Inc.
AGrant or award
Common Stock
+31,250$0.00$031,250Jul 27, 2026
Jul 23, 2026IMNM
Immunome Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+62,500$0.00$062,500Jul 27, 2026
Jul 7, 2026IMNM
Immunome Inc.
MOption exercise
Common Stock10b5-1
+1,092$12.92$14k1,092Jul 9, 2026
Jul 7, 2026IMNM
Immunome Inc.
SOpen-market sale
Common Stock10b5-1
-1,092$25.00$27k0Jul 9, 2026
Jul 7, 2026IMNM
Immunome Inc.
MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
-1,092$0.00$0128,908Jul 9, 2026
Jul 29, 2025IMNM
Immunome Inc.
AGrant or award
Employee Stock Option (right to buy)derivative
+161,000$0.00$0161,000Jul 31, 2025
Aug 9, 2024IMNM
Immunome Inc.
AGrant or award
Stock option (right to buy)derivative
+130,000$0.00$0130,000Aug 13, 2024
Feb 20, 2024IMNM
Immunome Inc.
AGrant or award
Stock option (right to buy)derivative
+300,000$0.00$0300,000Feb 21, 2024

Questions about Kinney Horn

Answered from the filings on this page, as of the latest one.

Is Kinney Horn buying or selling?

In the last 12 months Kinney Horn reported 0 open-market buys worth $0 and 2 open-market sells worth $2.3M on SEC Form 4; the latest was sold $2.3M of IMNM on Aug 4, 2026. Grants, option exercises and tax withholding are not counted.

How did Kinney Horn's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kinney Horn has 0.

Where does Kinney Horn file Form 4?

Kinney Horn has filed Form 4 at IMNM (Immunome Inc.) as CHIEF BUSINESS OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kinney Horn: insider trades and track record | InsiderTell